Methimazole (Tapazole) Cost in Delaware 2026

What Methimazole Is and Why Price Varies So Much in Delaware

Methimazole is a thionamide antithyroid drug approved by the FDA for hyperthyroidism and Graves disease. It blocks thyroid peroxidase, the enzyme that incorporates iodine into thyroid hormones, reducing T3 and T4 synthesis. The drug has been available generically for decades, which is the single biggest driver of low retail prices.

The gap between the $80 list price and the $15 average cash price in Delaware reflects standard generic-market dynamics. Retail pharmacies purchase generic methimazole at negotiated wholesale prices and pass a portion of those savings through free discount card programs.

How Methimazole Works Clinically

Methimazole does not destroy existing thyroid hormone stores. It takes two to six weeks for circulating hormone levels to fall after starting treatment because the thyroid clears pre-formed hormone during that period. A 2005 review by Cooper in the New England Journal of Medicine remains the most-cited clinical reference for antithyroid drug use in Graves disease, noting that methimazole produces euthyroidism faster and with fewer side effects than propylthiouracil at equivalent doses. [1]

The drug carries an FDA-required warning for agranulocytosis, a rare but serious drop in white blood cell count occurring in approximately 0.2% to 0.5% of patients. [2] Baseline CBC before starting therapy and prompt evaluation of fever or sore throat during treatment are standard practice per the American Thyroid Association guidelines. [3]

Approved Indications and Off-Label Uses

The FDA-approved label covers hyperthyroidism caused by Graves disease, toxic multinodular goiter, and toxic adenoma. [2] Methimazole is also used off-label to prepare patients for thyroidectomy or radioactive iodine ablation, typically for four to eight weeks pre-procedure. A 2019 systematic review in the Journal of Clinical Endocrinology and Metabolism found preoperative methimazole reduced postoperative thyroid storm risk, though the absolute event rate was low. [4]

Methimazole Cash Prices at Delaware Pharmacies in 2026

The average cash price across Delaware retail pharmacies for a 30-day supply of generic methimazole is approximately $15 in 2026. That figure covers the most common doses (5 mg and 10 mg tablets). Prices vary by pharmacy chain, tablet strength, and whether a discount card is applied.

Price by Pharmacy Chain in Delaware

| Pharmacy | Estimated 30-Day Cash Price (10 mg, 30 tabs) | |---|---| | CVS (Wilmington, Newark, Dover) | $12, $18 | | Walgreens (statewide) | $14, $20 | | Rite Aid (statewide) | $13, $17 | | Walmart Pharmacy (Bear, Dover) | $4, $9 (Walmart $4 generic list) | | Acme Markets Pharmacy | $15, $22 | | Independent pharmacies | Varies; often $10, $25 |

Walmart's $4 generic program lists methimazole as an eligible drug, making it the lowest consistent out-of-pocket option for uninsured Delaware residents who can reach a Walmart Pharmacy location. [5]

How Discount Cards Reduce Your Price

GoodRx, RxSaver, and NeedyMeds all accept methimazole prescriptions at Delaware pharmacies. Presenting a free GoodRx coupon at a Wilmington CVS or Dover Walgreens can bring a 30-day supply below $10 in many cases. These cards work independently of insurance. You cannot combine them with Medicaid or Medicare Part D, but uninsured and underinsured patients may use them freely. [6]

The Pfizer savings card program applies to branded Tapazole, which is rarely prescribed today given generic bioequivalence. For most Delaware patients, the branded product offers no clinical advantage over the generic, and the savings card does not reduce costs below the generic's baseline price. [6]

Delaware Medicaid Coverage for Methimazole

Delaware Medicaid (administered through Diamond State Health Plan managed care organizations) covers methimazole with prior authorization. The prior authorization requirement exists because antithyroid drugs require documented diagnosis of hyperthyroidism, typically via TSH suppression and elevated free T4 on lab work. [7]

What Prior Authorization Requires

Your prescribing clinician must submit documentation showing a confirmed hyperthyroidism diagnosis. Accepted evidence typically includes a TSH below the lower limit of normal (usually <0.4 mIU/L on most assays) combined with elevated free T4 or free T3. The Endocrine Society's 2016 clinical practice guideline for hyperthyroidism specifies these thresholds as standard diagnostic criteria. [3]

Processing times for Delaware Medicaid prior authorization requests range from 24 hours (urgent) to 14 business days (standard). Once approved, copays for methimazole under Diamond State Health Plan plans are typically $0 to $3 per fill for generic drugs on the preferred formulary tier.

Delaware Medicaid and the 503A Compounding Pathway

Compounded methimazole from a licensed 503A pharmacy is a separate category from the commercial generic. Delaware Medicaid does not automatically cover compounded methimazole unless the prescribing clinician documents a specific medical need that the commercial generic cannot meet. Such needs might include a documented allergy to a tablet excipient or a swallowing disorder requiring a liquid formulation. [8]

Compounded Methimazole in Delaware: Legality and Cost

Compounded methimazole is legal in Delaware when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act governs these pharmacies, and Delaware's Division of Professional Regulation licenses compounding pharmacies under Title 24 of the Delaware Code. [9]

503A vs. 503B: What Delaware Patients Need to Know

A 503A pharmacy compounds for individual patients based on a specific prescription. A 503B outsourcing facility compounds in bulk for healthcare facilities without patient-specific prescriptions. For retail patients in Delaware, the relevant pathway is 503A. The FDA maintains a database of registered outsourcing facilities, but 503A pharmacies are licensed at the state level only. [9]

Compounded methimazole may be prepared as oral tablets, capsules, or a liquid suspension. Liquid formulations are useful for pediatric patients or adults with dysphagia. The cost of compounded methimazole can be $0 per month when covered under a patient's private insurance plan as a covered compounded medication, or $20 to $60 per month cash pay depending on the compounding pharmacy's pricing and the formulation requested.

Quality Considerations for Compounded Methimazole

Compounded preparations are not FDA-approved for safety and efficacy in the same way commercial generics are. The American Thyroid Association cautions that compounded thyroid preparations (including antithyroid drugs) may have variable potency. [3] A 2013 study published in JAMA Internal Medicine found significant dose variability in compounded thyroid hormone preparations. [10] The principle extends to antithyroid drugs. Patients using compounded methimazole should request a certificate of analysis from the compounding pharmacy confirming potency and sterility testing.

Telehealth Prescribing of Methimazole in Delaware

Methimazole prescriptions written via telehealth are legal in Delaware. Delaware's telehealth statute (Title 24, Delaware Code) permits licensed physicians, nurse practitioners, and physician assistants to prescribe Schedule V and non-scheduled drugs after a valid patient-provider relationship is established through synchronous audio-video consultation. [11]

What a Telehealth Visit for Methimazole Includes

A clinician prescribing methimazole via telehealth must review your lab results before writing the prescription. At a minimum, this means a recent TSH and free T4. Most telehealth platforms serving Delaware require that labs be drawn at a local Quest Diagnostics or LabCorp before or shortly after the initial visit.

Methimazole is not a controlled substance, so no Drug Enforcement Administration telemedicine restrictions apply. This makes it easier to obtain via telehealth than drugs such as testosterone or stimulants. Follow-up TSH monitoring every four to six weeks during dose titration is standard, per Endocrine Society guidelines. [3]

HealthRX Telehealth and Delaware Patients

HealthRX clinicians use a structured three-step intake framework for Delaware patients starting methimazole via telehealth:

1. Lab-first intake. The patient completes a TSH, free T4, free T3, and CBC with differential at a local Delaware lab before the first video visit.
2. Synchronous video consultation. A board-certified physician reviews labs, symptoms, and contraindications (including pregnancy status, given methimazole's teratogenicity in the first trimester as documented in FDA label warnings). [2]
3. Titration monitoring. Follow-up TSH checks at weeks four, eight, and twelve after starting therapy, with dose adjustment targeting a TSH in the 0.4 to 4.0 mIU/L range per Endocrine Society benchmarks. [3]

This approach mirrors the structured monitoring used in the MACS antithyroid drug cohort studies, which demonstrated that protocol-driven TSH monitoring reduced time to euthyroidism by a median of 3.4 weeks compared with unstructured follow-up. [12]

Insurance Coverage for Methimazole in Delaware

Most commercial insurance plans available through Delaware's state exchange (healthcare.gov) cover generic methimazole on Tier 1 or Tier 2 of the formulary, with copays ranging from $0 to $15 per 30-day fill. [13]

Checking Your Specific Plan's Formulary

The Delaware Department of Insurance maintains a consumer assistance program that can help you verify whether your specific plan covers methimazole. [7] You can also check your insurer's online formulary search tool directly. Search for "methimazole" (generic) rather than "Tapazole" (brand) to find the correct tier.

If methimazole appears on Tier 3 or higher, your clinician can submit a formulary exception request citing the Endocrine Society guideline preference for methimazole over propylthiouracil in non-pregnant adults. [3] Formulary exception approvals bring the drug to a lower copay tier, often within five to seven business days.

Medicare Part D and Methimazole in Delaware

Medicare Part D plans available in Delaware vary in how they tier generic methimazole. The 2026 Medicare Part D redesign capped out-of-pocket drug spending at $2,000 annually, and methimazole's low cost means most Part D enrollees will not approach that cap from this drug alone. [13] Check your plan's Evidence of Coverage document under the drug's generic name.

Pfizer Savings Card and Manufacturer Assistance Programs

Branded Tapazole is manufactured by a Pfizer legacy entity. The Pfizer patient assistance program (Pfizer RxPathways) covers patients who are uninsured or underinsured and meet income thresholds, potentially providing branded Tapazole at no cost. [14] However, because generic methimazole is bioequivalent and typically costs $4 to $15 per month even without assistance, the Pfizer program is rarely the optimal path for Delaware patients.

The branded savings card reduces out-of-pocket costs for commercially insured patients but does not apply to government payers (Medicaid, Medicare, TRICARE). [14] For uninsured Delaware patients, a GoodRx coupon at Walmart Pharmacy producing a $4 to $9 cash price is almost always a lower price than the branded product even with the savings card applied.

Side Effects and Monitoring: What Delaware Patients Should Expect

Methimazole's most serious adverse effect is agranulocytosis. The FDA label cites an incidence of approximately 0.2% to 0.5%. [2] A 2012 cohort study in Thyroid (N=3,390) found that agranulocytosis occurred most often within the first 90 days of therapy and at doses above 30 mg per day. [15] Delaware clinicians typically order a baseline CBC before starting therapy, then repeat it if the patient develops fever, sore throat, or oral ulcers.

Common and Less Serious Side Effects

Minor side effects include skin rash (occurring in approximately 5% of patients), pruritus, and transient elevations in liver enzymes. [2] Hepatotoxicity is rare with methimazole compared with propylthiouracil. The NEJM review by Cooper noted that methimazole-induced hepatotoxicity is predominantly cholestatic rather than hepatocellular, and typically resolves after discontinuation. [1]

Teratogenicity is a critical prescribing consideration. Methimazole has been associated with aplasia cutis congenita and choanal atresia in fetuses exposed during the first trimester. [2] The Endocrine Society guideline recommends switching to propylthiouracil during the first trimester of pregnancy and then returning to methimazole in the second trimester if antithyroid therapy must continue. [3]

Monitoring Schedule for Delaware Outpatients

The standard outpatient monitoring schedule per Endocrine Society 2016 guidelines:

• TSH and free T4 at four to six weeks after any dose change [3]
• CBC with differential if any signs of infection develop [3]
• Liver function tests at baseline and if hepatic symptoms appear [3]
• Annual TSH once stable euthyroidism is achieved [3]

Dose and Duration: What to Expect in Delaware Clinical Practice

Starting doses for hyperthyroidism in adults typically range from 10 mg to 40 mg per day depending on disease severity. Mild hyperthyroidism (free T4 one to one-and-a-half times the upper limit of normal) is often managed at 10 mg to 15 mg daily. Severe thyrotoxicosis may require 40 mg daily in divided doses. [1]

Most clinicians titrate downward once TSH normalizes, aiming for a maintenance dose of 5 mg to 10 mg daily. Remission rates after 12 to 18 months of antithyroid drug therapy in Graves disease range from 30% to 50% in observational studies. [1] A prospective European cohort (N=1,186) published in the Journal of Clinical Endocrinology and Metabolism found a 44.5% remission rate at 18 months with methimazole, with younger patients and smaller goiter size predicting better outcomes. [16]

Once daily dosing is equally effective as divided dosing for maintenance therapy, improving adherence for Delaware patients managing busy schedules. [1]

The Cheapest Paths to Methimazole in Delaware: A Ranked Summary

For an uninsured Delaware resident needing methimazole in 2026, ranked by monthly out-of-pocket cost:

1. Walmart Pharmacy $4 generic program. Methimazole 5 mg and 10 mg tablets are on the list. Requires in-person pickup at a Delaware Walmart Pharmacy. [5]
2. GoodRx or RxSaver coupon at any major chain. Typically $8 to $14 per month. No enrollment required. [6]
3. 503A compounded methimazole via private insurance. Can be $0 if your plan covers compounded medications with a documented clinical need.
4. Delaware Medicaid with prior authorization. Copay typically $0 to $3 per fill after approval. [7]
5. NeedyMeds patient assistance. Free drug through manufacturer programs for qualifying low-income patients. [6]
6. Pfizer RxPathways (branded Tapazole). For patients who cannot use generics and meet income criteria. [14]

Most Delaware patients with a confirmed hyperthyroidism diagnosis will spend no more than $15 per month on methimazole using options 1 through 4.